Ye Lu

486 total citations
21 papers, 323 citations indexed

About

Ye Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ye Lu has authored 21 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Ye Lu's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (4 papers). Ye Lu is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (4 papers). Ye Lu collaborates with scholars based in China and United States. Ye Lu's co-authors include Li Cui, Xinyuan Zhao, Zizhao Mai, Yuanyuan Liu, Yunfan Lin, Xiaojing Meng, Hangming Dong, Yujie Qiao, Xinyuan Zhao and Yucheng Zheng and has published in prestigious journals such as ACS Nano, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Ye Lu

17 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ye Lu China	11	181	107	90	41	32	21	323
Shu Xu China	7	163 0.9×	126 1.2×	104 1.2×	40 1.0×	34 1.1×	11	315
Juntao Huang China	12	119 0.7×	92 0.9×	83 0.9×	29 0.7×	71 2.2×	39	317
Sengwang Fu China	11	143 0.8×	84 0.8×	72 0.8×	35 0.9×	46 1.4×	20	316
Lianjun Lin China	10	285 1.6×	107 1.0×	183 2.0×	38 0.9×	28 0.9×	14	407
Casper J.E. Wahlund Sweden	7	268 1.5×	86 0.8×	117 1.3×	135 3.3×	36 1.1×	8	399
Andrew Warner United States	10	99 0.5×	54 0.5×	88 1.0×	33 0.8×	83 2.6×	26	293
Lei Cai China	10	157 0.9×	103 1.0×	128 1.4×	29 0.7×	71 2.2×	30	308
Ida Russo Italy	10	148 0.8×	72 0.7×	96 1.1×	24 0.6×	44 1.4×	22	280
Ari Jón Arason Iceland	9	131 0.7×	150 1.4×	59 0.7×	18 0.4×	76 2.4×	11	321

Countries citing papers authored by Ye Lu

Since Specialization

Citations

This map shows the geographic impact of Ye Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Lu more than expected).

Fields of papers citing papers by Ye Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Lu. The network helps show where Ye Lu may publish in the future.

Co-authorship network of co-authors of Ye Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Lu. A scholar is included among the top collaborators of Ye Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Lu. Ye Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ren, Xiaobing, Song Wang, Zelin Cao, et al.. (2025). A Cross‐Scale Memristor‐Based Neuromorphic Platform Bridging Physical Encoding and Medical Inference. Advanced Functional Materials. 36(20).

Mai, Zizhao, Ye Lu, Yunfan Lin, et al.. (2025). METTL1-driven epitranscriptomic enhancement of TXNDC12 boosts c-Myc stability through USP5 in HNSCC. Experimental & Molecular Medicine. 57(8). 1743–1758.

Cui, Li, Zizhao Mai, Ye Lu, et al.. (2025). Laboratory investigation of METTL7A driving MSC osteogenic differentiation through YAP1 translation enhancement via eIF4F recruitment. International Endodontic Journal. 58(4). 587–603.

Mai, Zizhao, Xu Chen, Ye Lu, et al.. (2025). Orchestration of immunoregulatory signaling ligand and receptor dynamics by mRNA modifications: Implications for therapeutic potential. International Journal of Biological Macromolecules. 310(Pt 1). 142987–142987. 1 indexed citations

Xie, Fang, Jia‐Yi Zhang, Yun Yu, et al.. (2025). TCA Cycle Intermediate Mitigates Di(2‐ethylhexyl) Phthalate‐Induced Cholestatic Liver Injury Through Modulation of the Nrf2/NQO1 Signalling Axis. Basic & Clinical Pharmacology & Toxicology. 136(6). e70047–e70047. 1 indexed citations

Lu, Ye, Pei Lin, Yunfan Lin, et al.. (2024). Tumor Microenvironment-Derived Exosomes: A Double-Edged Sword for Advanced T Cell-Based Immunotherapy. ACS Nano. 18(40). 27230–27260. 16 indexed citations

Lin, Yunfan, Pei Lin, Ye Lu, et al.. (2024). Post‐Translational Modifications of RNA‐Modifying Proteins in Cellular Dynamics and Disease Progression. Advanced Science. 11(44). e2406318–e2406318. 11 indexed citations

Lu, Ye, et al.. (2023). Constructing a T-Cell Receptor-Related Gene Signature for Prognostic Stratification and Therapeutic Guidance in Head and Neck Squamous Cell Carcinoma. Cancers. 15(23). 5495–5495. 2 indexed citations

Lu, Ye, Zizhao Mai, Li Cui, & Xinyuan Zhao. (2023). Engineering exosomes and biomaterial-assisted exosomes as therapeutic carriers for bone regeneration. Stem Cell Research & Therapy. 14(1). 55–55. 58 indexed citations

10.

Lu, Ye, et al.. (2023). Epitranscriptomic modifications in mesenchymal stem cell differentiation: advances, mechanistic insights, and beyond. Cell Death and Differentiation. 31(1). 9–27. 26 indexed citations

11.

Cui, Li, et al.. (2023). ACTN1 promotes HNSCC tumorigenesis and cisplatin resistance by enhancing MYH9-dependent degradation of GSK-3β and integrin β1-mediated phosphorylation of FAK. Journal of Experimental & Clinical Cancer Research. 42(1). 335–335. 18 indexed citations

12.

Liu, Yuanyuan, Shuyu Chen, Li Yu, et al.. (2022). Pemafibrate attenuates pulmonary fibrosis by inhibiting myofibroblast differentiation. International Immunopharmacology. 108. 108728–108728. 15 indexed citations

13.

Liu, Yuanyuan, Shuyu Chen, Li Yu, et al.. (2022). Pemafibrate Attenuates Pulmonary Fibrosis by Inhibiting Myofibroblast Differentiation. SSRN Electronic Journal.

14.

Liu, Yuanyuan, Ye Lu, Yujie Qiao, et al.. (2022). HDM induce airway epithelial cell ferroptosis and promote inflammation by activating ferritinophagy in asthma. The FASEB Journal. 36(6). e22359–e22359. 57 indexed citations

15.

Liu, Yuanyuan, Ye Lu, Yujie Qiao, et al.. (2022). Extracellular HSP90α promotes cellular senescence by modulating TGF ‐β signaling in pulmonary fibrosis. The FASEB Journal. 36(8). e22475–e22475. 10 indexed citations

16.

Liu, Yuanyuan, Ye Lu, Yujie Qiao, et al.. (2021). Extracellular HSP90α Interacts With ER Stress to Promote Fibroblasts Activation Through PI3K/AKT Pathway in Pulmonary Fibrosis. Frontiers in Pharmacology. 12. 708462–708462. 7 indexed citations

17.

Liu, Yuanyuan, Ye Lu, Xiaojing Meng, et al.. (2021). Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis. Frontiers in Pharmacology. 12. 744826–744826. 42 indexed citations

18.

Liu, Yuanyuan, et al.. (2021). Tetrandrine Modulates Rheb-mTOR Signaling-Mediated Selective Autophagy and Protects Pulmonary Fibrosis. Frontiers in Pharmacology. 12. 739220–739220. 28 indexed citations

19.

Liu, Qiuping, Pan Ge, Shuyu Zhang, et al.. (2021). Circular RNA-CDR1as is involved in lung injury induced by long-term formaldehyde inhalation. Inhalation Toxicology. 33(9-14). 325–333. 8 indexed citations

20.

Yu, Yanhua, Ye Lu, Yong-Qiang He, Sheng Huang, & Ji‐Liang Tang. (2015). Rapid and efficient genome-wide characterization of Xanthomonas TAL effector genes. Scientific Reports. 5(1). 13162–13162. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact